US FDA grant emergency approval for Roche’s COVID-19 Antibody Test

Roche has stated the test has a specificity greater than 99.8% and this should mean fewer false-positive results, particularly if the individual has antibodies for other coronaviruses.

Source:

Biospace Inc.